🇺🇸 FDA
Patent

US 7919477

Multiple CpG oligodeoxynucleotides and their use to induce an immune response

granted A61KA61K2039/55561A61P

Quick answer

US patent 7919477 (Multiple CpG oligodeoxynucleotides and their use to induce an immune response) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K2039/55561, A61P, A61P31/04, A61P31/10